. 3,4--1H-4,3-a, , SEAr. in silico . II IV LD50 10-1500 /. . ADME- , in vitro .
Share your take
Add a clinician perspective alongside expert commentary.
Aleksandrova et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: